Related Experiment Video

Updated: Jul 9, 2026

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
06:29

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells

Haijun Zhang1, Gang Liu, Michele Dziubinski

  • 1Breast Cancer Program, Karmanos Cancer Institute, Detroit, MI 48201, USA.

Breast Cancer Research and Treatment
|December 13, 2007
PubMed

Insights

Different PIK3CA gene mutations in breast cancer exhibit distinct biological effects. Understanding these variations is crucial for developing targeted therapies for PIK3CA-mutated breast cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Over 20 PIK3CA gene mutations are found in breast cancer, but their differing biological impacts remain unclear.
  • The PIK3CA gene is frequently mutated in various cancers, including breast cancer, highlighting its role in tumorigenesis.

Purpose of the Study:

  • To investigate the differential biological effects of various PIK3CA mutations in breast cancer.
  • To establish a cell model for studying the functional consequences of distinct PIK3CA mutations.

Main Methods:

  • A novel cell model was created using a lentivirus system to express 10 different PIK3CA genes (wild type and mutants) in MCF10A human mammary epithelial cells.
  • Functional assays included cell proliferation, EGF-independent growth, 3D Matrigel morphogenesis, colony formation, and cell invasion.
  • Western blotting was used to assess the activation of downstream signaling pathways (p-AKT, p-p70-S6K).

Main Results:

  • Nine distinct PIK3CA mutants demonstrated varying abilities to promote cell proliferation and EGF-independent growth.
  • Most PIK3CA mutants altered MCF10A cell morphogenesis in 3D Matrigel assays, with exceptions noted.
  • Mutant PIK3CA variants differentially enhanced colony formation and cell invasion, and activated AKT/p70S6K signaling independently of EGF.

Conclusions:

  • Different PIK3CA mutations contribute distinctively to breast cancer development and progression.
  • The PI3K inhibitor LY294002 effectively suppressed cell growth across various PIK3CA mutant lines.
  • Targeting specific PIK3CA mutations may offer personalized therapeutic strategies for breast cancer patients.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...